Brief: Immutep's Efti Reports Positive Initial Clinical Data
02/05/2024 13:15
May 2 (Reuters) - Immutep Ltd IMM.AX :
* POSITIVE INITIAL CLINICAL DATA REPORTED FROM IMMUTEP’S
EFTI
COMBINED WITH RADIOTHERAPY AND CHECKPOINT INHIBITOR FROM PHASE
II TRIAL IN SOFT TISSUE SARCOMA
Source text for Eikon: ID:nGNX2zBkLR
Further company coverage: IMM.AX
((reuters.briefs@thomsonreuters.com;))